Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Davor Galusic"'
Autor:
Marko Lucijanic, Ivan Krecak, Ena Soric, Anica Sabljic, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Josipa Budimir, Rajko Kusec
Publikováno v:
Life, Vol 14, Iss 4, p 523 (2024)
Aim: To investigate the prognostic contribution of absolute neutrophil (ANC), lymphocyte (ALC), platelet count and their ratios, neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR), to thrombotic risk in patients with prefibroti
Externí odkaz:
https://doaj.org/article/f29cde860d624bb4adeeb79a53310d33
Autor:
Ivan Krecak, Dragana Grohovac, Nikolina Vucenovic Basic, Monika Ceko, Karla Nizetic, Anica Sabljic, Hrvoje Holik, Davor Galusic, Ivan Zekanovic, Martina Morić Perić, Vlatka Perisa, Marko Lucijanic
Publikováno v:
HemaSphere, Vol 7, p e975318d (2023)
Externí odkaz:
https://doaj.org/article/95372950acb64ebba4982b0845b08e6a
Autor:
Marko Lucijanic, Ivan Krecak, Ena Soric, Anica Sabljic, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Morić Perić, Ivan Zekanovic, Rajko Kušec
Publikováno v:
HemaSphere, Vol 7, p e80756cf (2023)
Externí odkaz:
https://doaj.org/article/c8f92c1985d84efdab0d2ab554e8806a
Autor:
Davor Galusic, Sandra Basic-Kinda, Andela Pijuk, Vibor Milunovic, Barbara Dreta, Neven Franjic, Bozena Coha, Jasminka Sincic-Petricevic, Petar Gacina, Vlatko Pejsa, Marko Lucijanic, Igor Aurer
Publikováno v:
HemaSphere, Vol 6, Iss 12, p e807 (2022)
Obinutuzumab (G) has become part of front-line treatment of follicular lymphoma (FL) based on results of a large randomized study. Data on patients treated outside of clinical trials are lacking. We have retrospectively investigated efficacy and safe
Externí odkaz:
https://doaj.org/article/488124ea74b64cb9b4bf303d49492770
Autor:
Zdravko Mitrovic, Dino Dujmovic, Ozren Jaksic, Sandra Basic Kinda, Petar Gacina, Vlatka Perisa, Zeljko Prka, Barbara Dreta, Davor Galusic, Hrvoje Holik, Vlatko Pejsa, Igor Aurer
Publikováno v:
European Journal of Haematology. 110:725-731
Autor:
Marko Lucijanic, Ivan Krecak, Ena Soric, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Rajko Kusec
Publikováno v:
Leukemia & Lymphoma
Volume 64
Issue 4
Volume 64
Issue 4
Splenomegaly s a hallmark ol primary (PMF) and secondary myelofibrosis {;SMF};, developing mostly due to extramedullary hematopoiesis. It represents tumour burden and correlates with unfavourable disease features. PMF and SMF may have distinct molecu
Autor:
Marko Lucijanic, Davor Galusic
Publikováno v:
Liječnički vjesnik. 144
Autor:
Marko Lucijanic, Ivan Krecak, Ena Soric, Anica Sabljic, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Rajko Kusec
Publikováno v:
Leukemia Research
Volume 119
Volume 119
Primary myelofibrosis (PMF), post-polycythemia vera (post-PV) and post-essential thrombocythemia (post-ET) secondary myelofibrosis (SMF) are chronic myeloproliferative neoplasms (MPNs) characterized by bone marrow fibrosis, splenomegaly and debilitat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dfd57625258718458811a60fa6de5d0
https://urn.nsk.hr/urn:nbn:hr:105:524953
https://urn.nsk.hr/urn:nbn:hr:105:524953
Autor:
Tajana Štoos-Veić, Marko Lucijanic, Hrvoje Holik, Martina Sedinic, Vlatko Pejša, Davor Galusic, Rajko Kusec, Ivan Zekanović, Martina Moric Peric, Ivan Krečak, Vlatka Periša
Publikováno v:
Wiener klinische Wochenschrift. 134:97-103
Background: Serum uric acid (SUA) can promote inflammation and is associated with increased cardiovascular morbidity. Primary (PMF) and secondary myelofibrosis (SMF) are myeloproliferative neoplasms characterized by high cellular turnover and substan
Publikováno v:
International Journal of General Medicine. 13:131-140
Purpose This cohort study aimed to determine patterns of glycemic fluctuation and changes in metabolic parameters during and after corticosteroid administration in newly diagnosed diffuse large B-cell lymphoma (DLBCL) patients treated with R-CHOP che